Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 HKD | +0.70% | -8.90% | -37.59% |
05-16 | InnoCare Pharma Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis | CI |
05-14 | Innocare Pharma Posts Q1 Loss | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.59% | 1.09B | |
+8.18% | 114B | |
+9.78% | 104B | |
-1.83% | 22.57B | |
-9.66% | 22.5B | |
-10.39% | 17.95B | |
-41.90% | 16.48B | |
-13.86% | 15.82B | |
+3.46% | 13.55B | |
+28.75% | 10.99B |
- Stock Market
- Equities
- 9969 Stock
- News InnoCare Pharma Limited
- Transcript : InnoCare Pharma Limited, H1 2023 Earnings Call, Aug 30, 2023